News

Endpoints News18m
Ab­b­Vie’s Rin­voq is ap­proved in gi­ant cell ar­teri­tis; Rel­ma­da shares blad­der can­cer da­ta
AbbVie's Rinvoq approved for giant cell arteritis in US; Relmada reports Phase 2 bladder cancer data; Novo Nordisk Foundation ...